Depending on the content you would like to see, certain cookies must be activated. Some are essential while others are necessary to improve your virtual event experience.
Essential cookies
These cookies are necessary to enable the full functionality of login, conferences and more. Therefore, these cookies cannot be deactivated.
Optional cookies
We would like to present you various contents for which cookies are required. To agree, please choose the according checkbox.
Cookie expiration date Cookie function Allows YouTube videos to be displayed. Additional cookies may be set by external provider.
Cookie expiration date Cookie function Activate the chat display. Additional cookies may be set by external providers.
Volv is a Digital Health & Life-Sciences company based in Switzerland.
Volv was founded to enable our customers and partners to take advantage of the latest developments in technology and data science to be better able to discover the insights from diverse data that they need to drive for better outcomes.
We are covering our product inTrigue at this event and you can pick up information here.
Volv - AI Powered Global Healthcare - Booth
Volv - AI Powered Global Healthcare - Christopher Rudolf, CEO
Volv - AI Powered Global Healthcare - Logo
AI powering global reach for rare diseases
Volv's methodology for difficult to diagnose and rare disease modelling
inTrigue is a completely new way to discover patients that typically cannot be found in any other way. We build models based on patients that have not been found, not those that have already been found. That means using machine learning with no labels. It is frankly revolutionary, and a large hope for undiagnosed populations.
inTrigue: Be ready for truly personalised medicine
We use high-sensitivity, proprietary technology that can detect digital biomarkers for any human disease. We chose to focus on difficult to diagnose conditions, where there is significant unmet need.
With inTrigue, it is now possible to transform disease management and treatment at the individual patient level. We reshape medical practice and facilitate significantly earlier patient diagnosis and more accurate targeting.
What inTrigue does very well
inTrigue develops robust models that can find undiagnosed and misdiagnosed patient cohorts for difficult to diagnose diseases with a very high degree of accuracy.
inTrigue relearns the model in every country, as individual country systems and data are so different. We take account of differences in
clinical thinking
language
data structures
population variance
We unlock the way to find patients accurately in any language and in almost any available data set.
Volv is a Digital Health & Life-Sciences company based in Switzerland.
Volv was founded to enable our customers and partners to take advantage of the latest developments in technology and data science to be better able to discover the insights from diverse data that they need to drive for better outcomes.
At this event, Christopher Rudolf, Founder & CEO and Mike Musson, Commercial Director will be on hand to take any questions and in the afternoon on Tuesday they are involved in the Brain Hackathon which you can watch via live streaming.
AI powering global reach for rare diseases
Volv's methodology for difficult to diagnose and rare disease modelling
inTrigue is a completely new way to discover patients that typically cannot be found in any other way. We build models based on patients that have not been found, not those that have already been found. That means using machine learning with no labels. It is frankly revolutionary, and a large hope for undiagnosed populations.
inTrigue: Be ready for truly personalised medicine
We use high-sensitivity, proprietary technology that can detect digital biomarkers for any human disease. We chose to focus on difficult to diagnose conditions, where there is significant unmet need.
With inTrigue, it is now possible to transform disease management and treatment at the individual patient level. We reshape medical practice and facilitate significantly earlier patient diagnosis and more accurate targeting.
What inTrigue does very well
inTrigue develops robust models that can find undiagnosed and misdiagnosed patient cohorts for difficult to diagnose diseases with a very high degree of accuracy.
inTrigue relearns the model in every country, as individual country systems and data are so different. We take account of differences in
clinical thinking
language
data structures
population variance
We unlock the way to find patients accurately in any language and in almost any available data set.
Volv - AI Powered Global Healthcare - inTrigue Case Study Download (1015 KB)Volv - AI Powered Global Healthcare - inTrigue Brochure Download (602 KB)
Volv - AI Powered Global Healthcare - InfoBox
Info
Volv is a Digital Health & Life-Sciences company based in Switzerland.
Volv was founded to enable our customers and partners to take advantage of the latest developments in technology and data science to be better able to discover the insights from diverse data that they need to drive for better outcomes.
We are covering our product inTrigue at this event and you can pick up information here.
Gallery
Volv - AI Powered Global Healthcare - Booth
Volv - AI Powered Global Healthcare - Christopher Rudolf, CEO
Volv - AI Powered Global Healthcare - Logo
Videos
AI powering global reach for rare diseases
Volv's methodology for difficult to diagnose and rare disease modelling
inTrigue is a completely new way to discover patients that typically cannot be found in any other way. We build models based on patients that have not been found, not those that have already been found. That means using machine learning with no labels. It is frankly revolutionary, and a large hope for undiagnosed populations.
inTrigue: Be ready for truly personalised medicine
We use high-sensitivity, proprietary technology that can detect digital biomarkers for any human disease. We chose to focus on difficult to diagnose conditions, where there is significant unmet need.
With inTrigue, it is now possible to transform disease management and treatment at the individual patient level. We reshape medical practice and facilitate significantly earlier patient diagnosis and more accurate targeting.
What inTrigue does very well
inTrigue develops robust models that can find undiagnosed and misdiagnosed patient cohorts for difficult to diagnose diseases with a very high degree of accuracy.
inTrigue relearns the model in every country, as individual country systems and data are so different. We take account of differences in
clinical thinking
language
data structures
population variance
We unlock the way to find patients accurately in any language and in almost any available data set.